Skip to content
  • Tuesday, 27 October 2026
  • 10:37 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • TWiV 1290: Clinical Update with Dr. Daniel Griffin and Vincent Racaniello Focuses on Longevity, Infectious Disease Metrics, and Public Health Policy
Microbiology & Immunology

TWiV 1290: Clinical Update with Dr. Daniel Griffin and Vincent Racaniello Focuses on Longevity, Infectious Disease Metrics, and Public Health Policy

Lina Irawan Oct 12, 2026 0

In the latest installment of the popular weekly clinical update series on This Week in Virology (TWiV), co-hosts Dr. Daniel…

Read More
Microbiology & Immunology

TWiV 1292: Clinical update with Dr. Daniel Griffin

Lina Irawan Oct 10, 2026 0

The landscape of American public health is undergoing a profound and troubling transformation, marked by institutional retreat, the resurgence of…

Read More
Laboratory Automation & Robotics

Before its recent Phase 3 LSD win, Definium modeled up to $70,000 a year for a therapy that could fill a clinical shift

Lana Keisha Oct 10, 2026 0

New York City–based Definium Therapeutics has reached a pivotal inflection point in the rapidly evolving landscape of psychedelic medicine. Following…

Read More
Laboratory Automation & Robotics

As the dream of the autonomous clinical trial dawns, agent supervision is today’s human job

Lana Keisha Oct 6, 2026 0

The landscape of modern drug development is currently undergoing a seismic shift, driven by an unprecedented explosion in data volume…

Read More
Microbiology & Immunology

TWiV 1284: Clinical update with Dr. Daniel Griffin

Lina Irawan Oct 5, 2026 0

Recorded in the wake of New Year celebrations, the latest installment of This Week in Virology (TWiV Episode 1284) brings…

Read More
Microbiology & Immunology

TWiV 1286: Clinical update with Dr. Daniel Griffin

Lina Irawan Oct 4, 2026 0

The landscape of public health and pediatric immunology has entered a period of unprecedented scrutiny as scientific and medical communities…

Read More
Microbiology & Immunology

TWiV 1288: Clinical update with Dr. Daniel Griffin

Lina Irawan Oct 4, 2026 0

In the latest installment of This Week in Virology, Episode 1288, clinical expert Dr. Daniel Griffin and co-host Vincent Racaniello…

Read More
Microbiology & Immunology

TWiV 1290: Clinical update with Dr. Daniel Griffin

Lina Irawan Oct 3, 2026 0

In the latest installment of the long-running science and public health podcast This Week in Virology (TWiV), virologist Vincent Racaniello…

Read More
Microbiology & Immunology

TWiV 1292: Clinical update with Dr. Daniel Griffin

Lina Irawan Oct 3, 2026 0

In the latest installment of their weekly clinical update, Dr. Daniel Griffin and virologist Vincent Racaniello delivered a sobering assessment…

Read More
Pharmaceutical R&D

AstraZeneca and Daiichi Sankyo Join Forces with Summit Therapeutics in Strategic Clinical Partnership to Evaluate Novel Oncology Combinations

Teuku Ryan Oct 2, 2026 0

The oncology landscape is undergoing a significant strategic consolidation as major pharmaceutical players align their pipelines to maximize the therapeutic…

Read More

Posts pagination

1 2 3 … 29
AbbVie’s Maviret cured 96% of HCV trial participants. The real world is more complicated.A microscopic organism from a pond at Oxford University Parks appears to use the genetic code in a way scientists had not seen before.Sai Life Sciences Hosts Landmark Biotech Pitch Day 2026 in Boston, Forging Critical Alliances for Future Drug DiscoveryPharma 50: Keytruda holds the top brand slot, but tirzepatide and semaglutide have already passed it at the molecule level in FY2025
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
Merck and Moderna’s cancer vaccine is customized for each patient’s tumorAn Unbiased Look at Google Gemini Omni: Features, Costs, and Market ComparisonESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial CancerLight-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
Lana Keisha Oct 27, 2026
Data Science & Bioinformatics
An Unbiased Look at Google Gemini Omni: Features, Costs, and Market Comparison
Evan Lee Salim Oct 27, 2026
Pharmaceutical R&D
ESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial Cancer
Teuku Ryan Oct 27, 2026
Advanced Materials Science
Light-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
Nila Kartika Wati Oct 27, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ